Steroid sparing in vasculitis: Myth or reality?

Hanberg, Jennifer S; Miloslavsky, Eli M

Hanberg, Jennifer S; Miloslavsky, Eli M.

Affiliation

Hanberg JS; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Miloslavsky EM; Rheumatology Unit, Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: emiloslavsky@mgh.harvard.edu.

Best Pract Res Clin Rheumatol ; 37(1): 101843, 2023 03.

Article in En | MEDLINE | ID: mdl-37355346

Subject(s)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Vasculitis; Humans; Glucocorticoids/therapeutic use; Immunosuppressive Agents/therapeutic use; Drug Therapy, Combination; Vasculitis/drug therapy; Steroids/therapeutic use; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy

Key words

Avacopan; Glucocorticoids; Steroid sparing; Toxicity; Vasculitis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Vasculitis / Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Limits: Humans Language: En Journal: Best Pract Res Clin Rheumatol Journal subject: REUMATOLOGIA Year: 2023 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google